Does LETERMOVIR Cause Product use in unapproved indication? 99 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 99 reports of Product use in unapproved indication have been filed in association with LETERMOVIR (PREVYMIS). This represents 7.0% of all adverse event reports for LETERMOVIR.
99
Reports of Product use in unapproved indication with LETERMOVIR
7.0%
of all LETERMOVIR reports
14
Deaths
28
Hospitalizations
How Dangerous Is Product use in unapproved indication From LETERMOVIR?
Of the 99 reports, 14 (14.1%) resulted in death, 28 (28.3%) required hospitalization, and 2 (2.0%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LETERMOVIR. However, 99 reports have been filed with the FAERS database.
What Other Side Effects Does LETERMOVIR Cause?
Off label use (277)
Drug ineffective (103)
Death (98)
Cytomegalovirus infection reactivation (89)
Cytomegalovirus infection (87)
No adverse event (69)
Hospitalisation (60)
Drug interaction (57)
Pathogen resistance (57)
Product dose omission issue (54)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which LETERMOVIR Alternatives Have Lower Product use in unapproved indication Risk?
LETERMOVIR vs LETROZOLE
LETERMOVIR vs LETROZOLE\RIBOCICLIB
LETERMOVIR vs LEUCOVORIN
LETERMOVIR vs LEUCOVORIN\LEUCOVORIN
LETERMOVIR vs LEUPROLIDE